BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38572385)

  • 21. Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations.
    Longoni M; Moncini S; Cisternino M; Morella IM; Ferraiuolo S; Russo S; Mannarino S; Brazzelli V; Coi P; Zippel R; Venturin M; Riva P
    Am J Med Genet A; 2010 Sep; 152A(9):2176-84. PubMed ID: 20683980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype?
    Brasil AS; Malaquias AC; Wanderley LT; Kim CA; Krieger JE; Jorge AA; Pereira AC; Bertola DR
    Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):717-22. PubMed ID: 21340158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome.
    Ko JM; Kim JM; Kim GH; Yoo HW
    J Hum Genet; 2008; 53(11-12):999-1006. PubMed ID: 19020799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable phenotypic expression in a large Noonan syndrome family segregating a novel SOS1 mutation.
    van Trier DC; Rinne T; Noordam K; Draaisma JM; van der Burgt I
    Am J Med Genet A; 2017 Nov; 173(11):2968-2972. PubMed ID: 28884940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
    Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
    Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to growth hormone in short children with Noonan syndrome: correlation to genotype.
    Binder G
    Horm Res; 2009 Dec; 72 Suppl 2():52-6. PubMed ID: 20029239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
    Stagi S; Ferrari V; Ferrari M; Priolo M; Tartaglia M
    Front Endocrinol (Lausanne); 2022; 13():951331. PubMed ID: 36060964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis.
    Takahara S; Inoue SI; Miyagawa-Tomita S; Matsuura K; Nakashima Y; Niihori T; Matsubara Y; Saiki Y; Aoki Y
    EBioMedicine; 2019 Apr; 42():43-53. PubMed ID: 30898653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome family.
    Moncini S; Bonati MT; Morella I; Ferrari L; Brambilla R; Riva P
    Eur J Hum Genet; 2015 Nov; 23(11):1531-7. PubMed ID: 25712082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotype-genotype analysis of 242 individuals with RASopathies: 18-year experience of a tertiary center in Brazil.
    Bertola DR; Castro MAA; Yamamoto GL; Honjo RS; Ceroni JR; Buscarilli MM; Freitas AB; Malaquias AC; Pereira AC; Jorge AAL; Passos-Bueno MR; Kim CA
    Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):896-911. PubMed ID: 33128510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [RAS/MAPK signal transduction pathway and its role in the pathogenesis of Noonan syndrome].
    Gos M; Leszkiewicz M; Abramowicz A
    Postepy Biochem; 2012; 58(3):255-64. PubMed ID: 23373411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway.
    Malaquias AC; Brasil AS; Pereira AC; Arnhold IJ; Mendonca BB; Bertola DR; Jorge AA
    Am J Med Genet A; 2012 Nov; 158A(11):2700-6. PubMed ID: 22887833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in severity of cardiovascular anomalies in children with Noonan syndrome based on the causative gene.
    Shehade-Awwad N; Yeshayahu Y; Pinhas-Hamiel O; Katz U
    Front Pediatr; 2022; 10():946071. PubMed ID: 36160796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I.
    Fabretto A; Kutsche K; Harmsen MB; Demarini S; Gasparini P; Fertz MC; Zenker M
    Eur J Med Genet; 2010; 53(5):322-4. PubMed ID: 20673819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac features of Noonan syndrome in Japanese patients.
    Ichikawa Y; Kuroda H; Ikegawa T; Kawai S; Ono S; Kim KS; Yanagi S; Kurosawa K; Aoki Y; Ueda H
    Cardiol Young; 2023 Apr; 33(4):564-569. PubMed ID: 35475426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.
    Tartaglia M; Kalidas K; Shaw A; Song X; Musat DL; van der Burgt I; Brunner HG; Bertola DR; Crosby A; Ion A; Kucherlapati RS; Jeffery S; Patton MA; Gelb BD
    Am J Hum Genet; 2002 Jun; 70(6):1555-63. PubMed ID: 11992261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Noonan syndrome: genetic and clinical update and treatment options].
    Carcavilla A; Suárez-Ortega L; Rodríguez Sánchez A; Gonzalez-Casado I; Ramón-Krauel M; Labarta JI; Quinteiro Gonzalez S; Riaño Galán I; Ezquieta Zubicaray B; López-Siguero JP
    An Pediatr (Engl Ed); 2020 Jul; 93(1):61.e1-61.e14. PubMed ID: 32493603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Noonan syndrome: from phenotype to growth hormone therapy].
    Malaquias AC; Ferreira LV; Souza SC; Arnhold IJ; Mendonça BB; Jorge AA
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):800-8. PubMed ID: 18797587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome.
    Neumann TE; Allanson J; Kavamura I; Kerr B; Neri G; Noonan J; Cordeddu V; Gibson K; Tzschach A; Krüger G; Hoeltzenbein M; Goecke TO; Kehl HG; Albrecht B; Luczak K; Sasiadek MM; Musante L; Laurie R; Peters H; Tartaglia M; Zenker M; Kalscheuer V
    Eur J Hum Genet; 2009 Apr; 17(4):420-5. PubMed ID: 18854871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.